​

Funding Round

Series B - Septerna

Series B - Septerna

Investment Firm

Overview

Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.

Announced Date

Jul 11, 2023

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

RA Capital Management

RA Capital Management

RA Capital Management is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

12

Investor Name
Participant InvestorCatalio Capital Management
Participant InvestorDeep Track Capital
Participant InvestorRA Capital Management
Participant InvestorInvus
Participant InvestorThird Rock Ventures

Round Details and Background

Septerna raised $150000000 on 2023-07-11 in Series B

Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 27, 2022
Series A - Septerna
7-100.0M
Jul 11, 2023
Series B - Septerna
15-150.0M

Recent Activity

There is no recent news or activity for this profile.